Found 153 matching trials
The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg PHASE4 HBeAg-negative chronic hepatitis B (CHB) patients with low Level HBsAg were...
Show More Location
Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC PHASE1 The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Show More Location
Baylor College of Medicine - Methodist Hospital
Learn More & Join Trial
Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C PHASE1 The purpose of this study is to (1) determine the effects of the herbal for...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C PHASE2 This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Show More Learn More & Join Trial
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin PHASE4 This is a 60-to-72 week multicenter study to evaluate Infergen and Ribaviri...
Show More Location
Atlantic Gastroenterology Associates
Learn More & Join Trial
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B PHASE3 Current clinical practices has shown promising prospects of the therapy str...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C PHASE2 This study is a multi-center, randomized, open-label and positive controlle...
Show More Location
302 Military Hospital
Learn More & Join Trial
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment PHASE2 The purpose of this study is to determine whether BMS-790052 added to Pegin...
Show More Location
Alabama Liver & Digestive Specialists (Alds)
Learn More & Join Trial